Studies have shown that the activated PI3K/AKT signaling pathway stimulates glucose uptake by regulating GLUT1 expression, enhances glycolysis, drives lactic acid production in cancer cells, inhibits macromolecular degradation, and affects tumor cell metabolism (Wasik and Lehtonen, 2018; Jin et al., 2021). This evidence concerns the gene SLC2A1 and cancer.